ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy

American Journal of Kidney Diseases

Volumn 35, Issue 1, 2000, Pages 58-63

  Stigant, Caroline E ^a   Cohen, Jamie ^a   Vivera, Maglin ^a   Zaltzman, Jeffrey S ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiotensin II antagonist; Angiotensin converting enzyme (ACE) inhibitor; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMMUNOSUPPRESSIVE AGENT; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAMIPRIL; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; COUGHING; DRUG INDUCED DISEASE; HUMAN; HYPERKALEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; TREATMENT OUTCOME;

EID: 0033970346     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70302-7     Document Type: Article

References (27)

1. PC Brazy WW Stead JF Fitzwilliam Progression of renal insufficiency: Role of blood pressure Kidney Int 35 1989 670 674
2. EJ Lewis LG Hunsicker RP Bain ED Rohde The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
3. I Giatras J Lau A Levey Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials Ann Intern Med 127 1997 337 345
4. H Benediktsson R Chea A Davidoff LC Paul Antihypertensive drug treatment in chronic renal allograft rejection in the rat: Effect on structure and function Transplantation 62 1996 1634 1642
5. LC Paul H Benediktsson Post transplant hypertension and chronic renal allograft failure Kidney Int 52 suppl 1995 S34 S37
6. S Anderson HG Rennke BM Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 7 1986 1993 2000
7. G Wolf G Neilson Angiotensin II as a renal growth factor J Am Soc Nephrol 3 1993 1531 1540
8. GH Gibbons RE Pratt VJ Dzau Vascular smooth muscle cell hypertrophy vs hyperplasia: Autocrine transforming growth factor-B expression determines growth response to Ang II in rat glomerular mesangial cells J Clin Invest 90 1992 456 461
9. S Kagami W Border D Miller N Nobel Angiotensin II stimulates extracellular matrix synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells J Clin Invest 93 1994 2427 2431
10. T Bochicchio G Sandoval O Ron H Perez-Grovas J Bordes J Herrera-Acosta Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives Kidney Int 38 1990 873 879
11. L Paul J Zaltzman The use of angiotensin-converting enzyme inhibitors in renal transplant patients Transplant Rev 12 1998 148 155
12. DE Hricik PJ Browning R Kopelman WE Goorno NE Madias VJ Dzau Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney N Engl J Med 308 1983 373 376
13. KA Nath AJ Crumbley BM Murray RK Sibley Captopril and renal insufficiency N Engl J Med 309 1983 666 (letter)
14. C Ponticelli G Montagnino A Aroldi C Angelini M Braga A Tarantino Hypertension after renal transplantation Am J Kidney Dis 4 suppl 2 1993 73 78
15. MR First PN Vaidya RK Maryniak MA Weiss R Munda JP Fidler I Penn JW Alexander Proteinuria following transplantation: Correlation with histopathology and outcome Transplantation 38 1984 607 612
16. G Remuzzi P Ruggenenti A Benigni Understanding the nature of renal disease progression Kidney Int 51 1997 2 15
17. AA Eddy Molecular insights into renal interstitial fibrosis J Am Soc Nephrol 7 1996 2495 2508
18. JE Hall TG Coleman AC Guyton JW Balfe HC Salgado Intrarenal role of angiotensin II and [des-Aspl]angiotensin II Am J Physiol 236 1979 F252 F259
19. H Velaquez MA Perazella FS Wright DH Ellison Renal mechanism of trimethoprim-induced hyperkalemia Ann Intern Med 119 1993 295 301
20. K Kamel JH Ethier S Quaggin A Levin S Albert EJ Carlisle ML Halperin Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporin J Am Soc Nephrol 2 1992 1279 1284
21. ER Swenson Severe hyperkalemia as a complication of timolol: A topically applied beta-adrenergic antagonist Arch Intern Med 146 1986 1220 1221
22. RS Gaston BA Julian JJ Curtis Posttransplant erythrocytosis: An enigma revisited Am J Kidney Dis 24 1994 1 11
23. FJ Dagher E Ramos AJ Earsley SV Alongi SA Karmi J Caro Are native kidneys responsible for erythrocytosis in renal allorecipient? Transplantation 26 1979 496 498
24. CH Sun HJ Ward WL Paul MA Koyle N Yanagawa DBN Lee Serum erythropoietin levels after renal transplantation N Engl J Med 321 1989 151 157
25. GL Barkis ER Sauter JL Hussey JW Fisher AO Gaber R Winsett The effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation N Engl J Med 323 1990 86 90
26. RJL Klaassen T Van Gelder J Rischen-Vos J Deinum AJ Man in't Veld W Weimar Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis Transplantation 64 1997 780 782
27. AG Brox J Mangel JA Hanley G St Louis S Mongrain RF Gagnon Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins Transplantation 66 1998 1053 1058